Nuveen Asset Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.84M | Sell |
127,747
-39,145
| -23% | -$2.1M | ﹤0.01% | 1824 |
|
|
2024
Q3 | $7.58M | Sell |
166,892
-230,014
| -58% | -$10.4M | ﹤0.01% | 1773 |
|
|
2024
Q2 | $16.6M | Buy |
396,906
+318,281
| +405% | +$13.3M | ﹤0.01% | 1251 |
|
|
2024
Q1 | $2.96M | Sell |
78,625
-2,949
| -4% | -$111K | ﹤0.01% | 2215 |
|
|
2023
Q4 | $875K | Buy |
81,574
+14,872
| +22% | +$160K | ﹤0.01% | 2796 |
|
|
2023
Q3 | $672K | Buy |
66,702
+7,957
| +14% | +$80.2K | ﹤0.01% | 2736 |
|
|
2023
Q2 | $697K | Buy |
58,745
+12,842
| +28% | +$152K | ﹤0.01% | 2807 |
|
|
2023
Q1 | $555K | Sell |
45,903
-14,814
| -24% | -$179K | ﹤0.01% | 2785 |
|
|
2022
Q4 | $799K | Sell |
60,717
-12,160
| -17% | -$160K | ﹤0.01% | 2763 |
|
|
2022
Q3 | $987K | Sell |
72,877
-1,996
| -3% | -$27K | ﹤0.01% | 2758 |
|
|
2022
Q2 | $915K | Buy |
74,873
+49,213
| +192% | +$601K | ﹤0.01% | 2825 |
|
|
2022
Q1 | $392K | Buy |
25,660
+6,203
| +32% | +$94.8K | ﹤0.01% | 3071 |
|
|
2021
Q4 | $345K | Hold |
19,457
| – | – | ﹤0.01% | 3147 |
|
|
2021
Q3 | $421K | Buy |
+19,457
| New | +$421K | ﹤0.01% | 3200 |
|